InvestorsHub Logo
Followers 6
Posts 829
Boards Moderated 0
Alias Born 09/01/2013

Re: Jockimo post# 9997

Thursday, 07/30/2015 10:02:56 PM

Thursday, July 30, 2015 10:02:56 PM

Post# of 474058
See Q3 data mention here from Missling.

http://act-ad.org/resources/q-anavex/

"The Phase 2a trial is a very exciting step. We dosed the first Alzheimer’s patient recently in January. The Company is looking forward to getting full trial data late this year, hopefully by third quarter of 2015."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News